arrow
H

Huahui Ren

BGI Genomics
H指数:20
被引数:4,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk

不同的年龄相关和代谢相关的肠道微生物组特征调节心血管疾病风险

2024-06-065
PRE
Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients

不同功能宏基因组标志物预测中国非小细胞肺癌患者对Anti-PD-1治疗的反应性

2022-04-2115
OAAI
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study
2021-12-2047
OAAI
Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients
2021-04-1345
OAAI
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
2020-10-06228
OAAI
Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naive type 2 diabetics
2019-09-01125
OAAI
Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children

早期事件和生活方式对学龄儿童肠道菌群及代谢表型的影响

2019-01-04143
OAAI
Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing

基于cPAS的宏基因组测序BGISEQ-500平台的评估

2017-12-2395
OAAI
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
2017-11-27327
OAAI
The gut microbiome in atherosclerotic cardiovascular disease

动脉粥样硬化性心血管疾病中的肠道微生物组

2017-10-101.1K
OAAI
Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals

脂质组学分析揭示了健康,糖尿病前期和2型糖尿病个体中血浆脂质组成的明显差异

2017-05-1538
OAAI